24-hour Efficacy and Tolerability of the Tafluprost-timolol Fixed Association Without Preservatives in Glaucomatous or Ocular Hypertensive Patients Already Treated With Latanoprost Preserved With BAK. A Prospective, Open Study of 3 Months Duration.
Conditions: Glaucoma, Open-Angle; Ocular Hypertension Intervention: Drug: tafluprost/timolol Sponsor: Fondazione G.B. Bietti, IRCCS Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 29, 2022 Category: Research Source Type: clinical trials
Evaluation of Nanodropper-mediated Microdrops vs. Standard Drops of 0.5% Timolol Maleate in Glaucoma Patients
Conditions: Glaucoma; Glaucoma, Open-Angle; Glaucoma, Primary Open Angle; Glaucoma and Ocular Hypertension; Ocular Hypertension Interventions: Device: Nanodropper adaptor; Other: Original eyedrop bottle/No Nanodropper Sponsors: Nanodropper, Inc.; Aravind Eye Care System Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 6, 2022 Category: Research Source Type: clinical trials
The Efficacy of Topical Timolol Combined With Cryotherapy in EGFR Inhibitors-induced Paronychia - a Double-blinded, Intrapatient Left-to-right Controlled Study
Conditions: Paronychia; Epidermal Growth Factor Receptor Inhibitor Interventions: Drug: Timolol maleate 0.5% ophthalmic solution; Procedure: Cryotherapy with liquid nitrogen Sponsor: Taipei Medical University WanFang Hospital Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 21, 2021 Category: Research Source Type: clinical trials
